Skip to content

Telecardio

Telemedicine in pediatric cardiology, a prospective study on multicenter collaboration - Telecardio

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58546
Enrollment
80
Registered
2026-03-26
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Not applicable. Not applicable.

Interventions

Teleconsult

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
No minimum to 99 Years

Inclusion criteria

Inclusion criteria: To be eligible to participate in this study, a subject must meet all of the following criteria:The patient is <18 years old.The patient is diagnosed with a heart disease (n=40).There is an indication for a referral from Amphia to the Erasmus MC, or from Erasmus MC to RadboudUMC, as these are the sites with (remote access to) the modern telemedicine device. Written informed consent.For Clinicians:The clinician has participated in the teleconsult.

Exclusion criteria

Exclusion criteria: Insufficient understanding of the Dutch language. 

Design outcomes

Primary

MeasureTime frame
The main endpoint is the usability of TeleCardio for parents and clinicians, evaluated using the an adapted telehealth usability questionnaire. For both clinicians and parents a score of 4 or higher, on a 1 to 5 Likert scale, will be deemed sufficient.The main endpoint is the usability of TeleCardio for parents and clinicians, evaluated using the an adapted telehealth usability questionnaire. For both clinicians and parents a score of 4 or higher, on a 1 to 5 Likert scale, will be deemed sufficient.

Secondary

MeasureTime frame
The following secondary outcomes are collected to assess feasibility, safety, satisfaction, and indicators of a change in decision-making. The reason for a reversal in decision-making after a joint tele-consult with patients and parents, where it was initially decided not to transfer. This will only be assessed if a decision to transfer during the virtual consults is revised > 2 hours after the teleconsults and if the reversal in decision-making occurs no longer than 48 hours after the teleconsults. This information will be retrieved from the EHR, and it will provide information on the safety of the workflow while performing joint virtual consults with parents and clinicians. Reported change in decision-making by the clinicians. The following question is asked to the participating clinicians from the Erasmus MC after every shared consult: “Did this teleconsult influence patient management?” This is in line with previous studies performed to measure the impact of virtual consults on clinical decision-making. As a follow-up, if the clinician answered “yes”, the clinician will be asked regarding the nature of the change, and whether the change in decision-making resulted in the postponement of a transfer. This will give a first estimation of a change in decision-making. Component scores of the aTUQ will be reported to assess usefulness, ease of use, effectiveness, reliability, and satisfaction. An optional field will be provided with the questionnaire to give additional free text feedback.Participating clinicians are asked to evaluate their current process regarding the transfer of patients at baseline, after 6 months or after 12 months if they performed their first teleconsult after 6 months.   

Countries

Netherlands

Contacts

Public ContactJ.P. Man

Erasmus MC, Universitair Medisch Centrum Rotterdam

j.man@erasmusmc.nl010-704 07 04

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 1, 2026